Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588679 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 265
- Enrollment target
NCT00588679: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00588679 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 265 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588679, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 265 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the benefits of Magnetic Resonance Imaging (MRI) combined with Magnetic Resonance Spectroscopic Imaging (MRSI), on an instrument called a 3.0 Tesla (T) MR scanner.
Interventions
- OTHER Magnetic Resonance Imaging; Spectroscopic Imaging, Contrast Enhanced Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2006-08-22 |
| Est. Completion | 2019-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588679
The ClinicalTrials.gov registry entry for NCT00588679 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Imaging; Spectroscopic Imaging, Contrast Enhanced Imaging is the first listed.
NCT00588679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588679 about?
NCT00588679 is a clinical study titled "Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla". The purpose of this study is to determine the benefits of Magnetic Resonance Imaging (MRI) combined with Magnetic Resonance Spectroscopic Imaging (MRSI), on an instrument called a 3.0 Tesla (T) MR scanner.
What is the current status of trial NCT00588679?
This trial is currently completed. It is a NA study. The enrollment target is 265 participants. The study started on 2006-08-22. Estimated completion is 2019-03-06.
What interventions are being tested in trial NCT00588679?
The interventions under investigation include: Magnetic Resonance Imaging; Spectroscopic Imaging, Contrast Enhanced Imaging (OTHER).
Who is sponsoring clinical trial NCT00588679?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.